Dr Vrushank Patel, MD | |
1101 W University Dr, Rochester, MI 48307-1863 | |
(248) 601-4805 | |
Not Available |
Full Name | Dr Vrushank Patel |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 1101 W University Dr, Rochester, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225655079 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 67421 (Tennessee) | Primary |
207R00000X | Internal Medicine | 4351046562 (Michigan) | Secondary |
Entity Name | Hospital Medicine Services Of Tn Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
Saint Mary's and Sierra Neurosurgery Group have partnered to create the region's first Brain Tumor Center in an effort to speed up the time between diagnosis and treatment.
According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.
The nation's medical workforce grapples with preventing falls in the hospital to improve patient safety. In the meantime, seniors in some places of the country are more likely to fill prescriptions for high-risk drugs, and Miami's seniors lead the nation in filling Medicare prescriptions.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia (BPH) and rates of active treatment for localized prostate cancer declined over six months.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Vrushank Patel, MD 7130 Brockton Dr, Kalamazoo, MI 49009-4122 Ph: (269) 501-5411 | Dr Vrushank Patel, MD 1101 W University Dr, Rochester, MI 48307-1863 Ph: (248) 601-4805 |
News Archive
Saint Mary's and Sierra Neurosurgery Group have partnered to create the region's first Brain Tumor Center in an effort to speed up the time between diagnosis and treatment.
According to the latest research lesser numbers of teenage girls and young women are getting infected by the human papillomavirus vaccine (HPV) – a virus linked to cervical cancer. Research also shows that most who start the vaccination regimen against the virus fail to take all three doses.
The nation's medical workforce grapples with preventing falls in the hospital to improve patient safety. In the meantime, seniors in some places of the country are more likely to fill prescriptions for high-risk drugs, and Miami's seniors lead the nation in filling Medicare prescriptions.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia (BPH) and rates of active treatment for localized prostate cancer declined over six months.
› Verified 8 days ago